01—History
Gross Profit History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2014–FY2019. Drag across the bars to change the range.
- $6.15B
1 older move runs past ±150% (largest +193.1%); point at, tap or drag across the bars to read one.
02—Ledger
Gross Profit, period by period
03—Questions
What is gross profit?
Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.
What is Regeneron Pharmaceuticals's current gross profit?
Regeneron Pharmaceuticals (REGN) annual gross profit for 2019 was $6.15B, a 25.40% increase from 2018. Regeneron Pharmaceuticals gross profit for the quarter ending March 31, 2018 was $1.44B.
What was Regeneron Pharmaceuticals's gross profit in 2018?
Regeneron Pharmaceuticals annual gross profit for 2018 was $4.91B, a 13.43% decline from 2017.
What was Regeneron Pharmaceuticals's gross profit in 2017?
Regeneron Pharmaceuticals annual gross profit for 2017 was $5.67B, a 21.52% increase from 2016.
What is Regeneron Pharmaceuticals's 5-year gross profit CAGR?
Regeneron Pharmaceuticals gross profit grew at a compound annual growth rate (CAGR) of 18.00% from FY2014 to FY2019, going from $2.69B to $6.15B over 5 years.
- Company
- Regeneron Pharmaceuticals
- Ticker
- REGN
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations